Strong Net Income Growth
Reported net income of $133 million or $0.22 per diluted share, and adjusted net income of $134 million or $0.23 per share, compared to $106 million and $0.18 per share in the previous quarter.
Deposit Growth and Cost Reduction
Added over 105,000 new deposit accounts, contributing to approximately 8% core deposit growth, alongside a 51 basis point reduction in average cost of deposits for Q2 2025 compared to Q2 2024.
Commercial Loan Diversification
C&I portfolio grew at a 19% compound annual rate since 2017, with nearly 15% growth over the last 12 months. Targeted growth in health care and fund finance verticals, with no losses in health care C&I loans over 20 years.
Noninterest Income Growth
Noninterest income grew at a 12% annual rate since 2017. Focus on capital markets, treasury management, and tax credit advisory contributed to more stable revenue streams.
Improved Efficiency Ratio
Efficiency ratio improved to 55.2%, the best level since Q1 2023, driven by strong revenue growth and continued cost discipline.